SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-176471
Filing Date
2022-06-17
Accepted
2022-06-17 16:00:58
Documents
13
Period of Report
2022-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d220959d8k.htm   iXBRL 8-K 30854
  Complete submission text file 0001193125-22-176471.txt   188436

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vor-20220614.xsd EX-101.SCH 3229
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vor-20220614_def.xml EX-101.DEF 13780
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vor-20220614_lab.xml EX-101.LAB 22695
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vor-20220614_pre.xml EX-101.PRE 14637
7 EXTRACTED XBRL INSTANCE DOCUMENT d220959d8k_htm.xml XML 5089
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39979 | Film No.: 221023651
SIC: 2836 Biological Products, (No Diagnostic Substances)